HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy Pryer Selected Research

Nancy Pryer Research Topics

Disease

5Neoplasms (Cancer)
01/2018 - 03/2007
2Breast Neoplasms (Breast Cancer)
11/2014 - 12/2013
2Carcinogenesis
04/2014 - 12/2013
1Disease Progression
12/2019
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
12/2019
1Carcinoma (Carcinomatosis)
11/2014
1Keratoacanthoma
04/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014
1Adenocarcinoma
03/2007

Drug/Important Bio-Agent (IBA)

1Tripeptidyl-Peptidase 1IBA
12/2019
1EnzymesIBA
12/2019
1Biomarkers (Surrogate Marker)IBA
12/2019
1Sunitinib (Sutent)FDA Link
01/2018
1Immunoconjugates (Immunoconjugate)IBA
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2018
1regorafenibIBA
01/2018
1Macrophage Colony-Stimulating FactorIBA
11/2014
1Carboplatin (JM8)FDA LinkGeneric
11/2014
1Interleukin-10 (Interleukin 10)IBA
11/2014
1Paclitaxel (Taxol)FDA LinkGeneric
11/2014
1Interleukin-10 ReceptorsIBA
11/2014
1VemurafenibIBA
04/2014
1Mitogen-Activated Protein KinasesIBA
04/2014
1DNA (Deoxyribonucleic Acid)IBA
04/2014
1Keratins (Keratin)IBA
12/2013
14- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA
12/2013
1Tumor Viral Antigens (Large T Antigen)IBA
12/2013
1CarbohydratesIBA
03/2007
1AntigensIBA
03/2007
1RAAG12IBA
03/2007
1Monoclonal AntibodiesIBA
03/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2014